Post-approval studies (Phase 4)Study completedNCT01914367
What this trial is testing
Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)
Who this might be right for
Infection With Human Papillomavirus
University Hospital, Ghent 12